跳至主要内容
临床试验/NCT00483626
NCT00483626Unknown4 期

Hemodynamic Evaluation of Patients With Pulmonary Arterial Hypertension. Response to Sildenafil Treatment

University of Chile2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2003年8月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
27
试验地点
2
主要终点
Arterial pulmonary resistance index

研究概览

简要总结

The purpose of this study is to determine the clinical, functional and hemodynamic response after six months of sildenafil 50 mg TID in patients with pulmonary arterial hypertension.

详细描述

Pulmonary arterial hypertension is a chronic devastating disease. There are few approval oral treatments. Sildenafil, a phosphodiesterase 5 inhibitors, has been recently approved for patients on functional class II and III showing hemodynamic benefits after 12 weeks of treatment. Long term hemodynamic evaluation after sildenafil treatment has not been evaluating in pulmonary arterial patients on functional class II to IV.

The protocol has been designed to evaluate patients on functional class II to IV from baseline conditions and after 6 months of sildenafil treatment (50 mg po TID). Clinical (functional class), functional (walked distance-6 minute walking test) and Hemodynamic evaluation is planned to be performed at baseline and after 6 months of treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 15 years old with Pulmonary arterial hypertension according with WHO hemodynamic definition,
  • Who signed informed consent,
  • Able to swallow tablets and follow instructions.

排除标准

  • Patients with pulmonary hypertension with other categories than pulmonary arterial hypertension (associated to COPD, lund diseases, sleep apnea, thromboembolic disease, hight altitude), patients asymptomatic, patients who were responders to adenosine during hemodynamic test, patients treated with specific treatments for pulmonary arterial hypertension before started the study such as sildenafil, prostanoids, endothelin receptors blockers.

结局指标

主要结局

Arterial pulmonary resistance index

时间窗: 6 months

次要结局

  • Mean pulmonary arterial pressure, Cardiac index, pulmonary saturation, walked distance, functional class.(6 months)

研究者

发起方
University of Chile
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Hemodynamic Response After Six Months of Sildenafil | 临床试验